New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Wissenschaftszweige

@article{beb01c08f40f459da891dc7c0528d358,

title = "New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management",

author = "Vrinda Saraff and Ruchi Nadar and Wolfgang H{\"o}gler",

year = "2020",

month = apr,

doi = "10.1007/s40272-020-00381-8",

language = "English",

volume = "22",

pages = "113--121",

journal = "Pediatric Drugs",

issn = "1179-2019",

number = "2",

}

TY - JOUR

T1 - New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management

AU - Saraff, Vrinda

AU - Nadar, Ruchi

AU - Högler, Wolfgang

PY - 2020/4

Y1 - 2020/4

UR - https://www.scopus.com/pages/publications/85078147743

U2 - 10.1007/s40272-020-00381-8

DO - 10.1007/s40272-020-00381-8

M3 - Article

C2 - 31965544

SN - 1179-2019

VL - 22

SP - 113

EP - 121

JO - Pediatric Drugs

JF - Pediatric Drugs

IS - 2

ER -